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A simple and sensitive assay has been developed that is capable of detecting as little as 0.2 
ng of the major isozyme of cytochrome P-450 (P-450b) isolated from the livers of phenobarbital- 
induced rats. This assay employs monoclonal antibodies generated against cytochrome P-450b 
to directly quantify the levels of this enzyme in various tissues. Separation of bound from free 
labeled antibody is achieved by using 6,9-diaminoacridine lactate (Rivanol). The useful range 
of the assay is between I and 100 ng of P-450b. o 1985 Academic press, IIIC. 
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In the past 10 years the known isozymes 
of cytochrome P-450 have increased from 
two to dozens. P-450s have been shown to 
exist in almost every tissue of mammals and 
are found in plants and bacteria as well. 
These multiple isozymes of P-450 have been 
shown to exhibit a certain degree of structural 
homogeneity, but differences have been found 
between homologous isozymes from closely 
related species. To quantify levels of these 
isozymes of cytochrome P-450 in various 
tissues, or to identify structural differences 
between closely related forms, investigators 
have turned to highly sensitive immuno- 
chemical assay techniques, often utilizing 
highly specific monoclonal antibodies 
(MAb’s).3 
This laboratory has been developing a 
sensitive immunochemical assay for the dif- 
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ferent isozymes of cytochrome P-450 which 
would be useful clinically. The assay being 
developed utilizes monoclonal antibodies. 
The standard radioimmunoassay did not 
work well with our monoclonal antibodies 
because of the insolubility of the labeled P- 
450 (1). A search of the literature for an 
alternative approach uncovered an article by 
Al-Shawi et al. (2) which led to the idea of 
using labeled antibody and Rivanol (6,9- 
diaminoacridine lactate) to separate bound 
from free fractions in a radiometric assay 
system. These authors reported that this re- 
agent precipitates the antibody-antigen com- 
plex while leaving the unbound antibody in 
solution. 
MATERIALS AND METHODS 
Rivanol (purity: 97-100%) was purchased 
from the Sigma Chemical Company. Purified 
rabbit P-450s (LM2, LM3a, LM3b, LM3c, 
LM4, and LM6) as well as phenobarbital 
(PB)-induced rabbit liver microsomes were 
generous gifts from Dr. Minor J. Coon, De- 
partment of Biological Chemistry, University 
of Michigan. Rat liver microsomes and cy- 
tochrome P-450~ were prepared by the 
method of Ryan et al. (3). Mitochondria 
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were prepared from rat liver by the method 
of Mitra and Bernstein (4). All of the rats 
used in these studies were of a CFN strain 
(Carsworth Farms) and were obtained from 
a randomly inbred colony maintained for 
over 15 years at the University of Michigan 
School of Public Health. 
Cytochrome P-450b was purified from the 
livers of PB-induced rats by the method of 
West et al. (5). The P-450b used in these 
experiments had a specific content of 16 
nmol/mg protein (1) and was shown to be 
purified to apparent homogeneity by the 
polyacrylamide gel electrophoresis technique 
of Laemmli (6). All protein measurements 
were made using the method of Lowry et 
al. (7). 
Monoclonal antibodies were generated 
against the P-450b antigen by the method 
previously described by Khazaeli et al. (8). 
Briefly, each of five female Balb/c mice was 
given an injection of 10 pg of P-450b ip 
emulsified in Freund’s complete adjuvant. 
The primary immunization was followed by 
two secondary immunizations in Freund’s 
incomplete adjuvant at 3-week intervals. 
Serum was collected 1 week after the final 
injection and tested for anti-P-450b titer 
via enzyme-linked immunosorbant assay 
(ELISA). The mouse with the highest titer 
was then given injections of antigen (10 pg 
each site) ip and iv in phosphate-buffered 
saline (PBS) 3 days prior to the fusion. On 
the day of the fusion; the mouse was sacri- 
ficed, its spleen was removed, and lympho- 
cytes isolated from the spleen were fused 
with cells of a nonsecreting myeloma cell 
line (X63-Ag8.653) by centrifugation in the 
presence of 15.6% polyethylene glycol 4000. 
Hybridoma 6C9 produced antibodies that 
reacted against the P-450b antigen, but 
showed no cross-reactivity for the P-450 spe- 
cies LM2, LM3a, LM3b, LM3c, LM4, and 
LM6 derived from the liver of the rabbit; or 
P-450~ from the rat when tested via ELISA 
(1). Antibodies from the 6C9.3 subclone 
(IGGl subclass) were purified by the method 
of Ey et al. (9) and labeled with iodine-125 
(‘251) by the method of Hunter and Green- 
wood (10). For these experiments, 4 fig of 
protein was reacted with 1.0 mCi of ‘25I 
yielding labeled MAb’s with a specific activity 
of approximately 40 &i/pg protein. The 
labeled antibodies were stored at 4°C in PBS 
containing 1% bovine serum albumin (BSA). 
The Rivanol Assay. Tissue samples to be 
assayed were diluted with 100 mM potassium 
phosphate buffer (pH 7.4) containing 30% 
glycerol, 1 mM ethylenediaminetetraacetic 
acid, and 0.3% sodium cholate to a concen- 
tration of 1 mg protein/ml. The diluted 
samples were allowed to incubate for at least 
20 min at room temperature with gentle 
mechanical shaking to ensure solubilization 
of P-450b. Pure P-450b standards were treated 
identically except that they were diluted to a 
protein concentration of 0.1 mg/ml in the 
solubilizing buffer. After solubilization, both 
samples and standards were diluted as nec- 
essary with PBS containing 1% BSA. Stan- 
dards and samples were prepared fresh for 
each assay because loss of binding activity 
was noted if they were allowed to sit in the 
solubilizing buffer for longer than a couple 
of days. 
The stock ‘2SI-labeled MAb’s were diluted 
to approximately 60,000 cpm/l50 ~1 with 
PBS containing 1% BSA immediately before 
use. The reaction was started by adding 150 
~1 of the labeled antibodies to 100 ~1 of the 
sample in 12 X 75 disposible glass tubes. 
After overnight incubation at room temper- 
ature with gentle shaking, 2 ml of 0.05% 
Rivanol in 10 mM sodium phosphate buffer 
(pH 7.4) was added to each tube. Sodium 
chloride was not added to this solution be- 
cause this salt will pecipitate the Rivanol. 
The tubes were mixed lightly using a Vortex 
mixer, allowed to stand at room temperature 
for 30 min, and then centrifuged at 1OOOg 
for 15 min at 15°C in an IEC Model PR-J 
refrigerated centrifuge. The P-450b-MAb 
complex formed a tight, bright-yellow pellet 
while the unbound MAb remained in solu- 
tion. The supematant solutions were aspirated 
and the tubes were counted for 1 min in a 
Micromedic 4-200 Plus y counter. Washing 
the pellet did not significantly reduce the 
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background counts, and was not done rou- 
tinely. 
RESULTS 
Figure 1 shows a typical standard curve 
generated by this radiometric assay. Each 
point shown represents the mean of triplicate 
analyses. The standard deviation for each 
point was less than 1% of the mean in all 
standard curves run by this method. When 
standard curves were generated using P-450b 
that had not been solubilized with cholate, 
the sensitivity of the assay was decreased 50- 
fold. The increased sensitivity of the standards 
using cholate-solubilized P-450b is presum- 
ably due to exposure of more antigenic bind- 
ing sites that occurs with the disruption of 
large P-450 polymers by the detergent. Be- 
cause the way in which the standards and 
samples are diluted results in a constant 
detergent-to-protein ratio and not a constant 
detergent concentration for all samples, it 
seems that the former is more important in 
generating the curves obtained. As can be 
seen in Fig. 1, as little as 0.2 ng of pure P- 
450b could be detected by this assay, with a 
useful range between 1 and 100 ng of protein. 
35000, 
FIG. 1. Standard curve obtained when 100 ~1 cold 
cytochrome P-450b is incubated with 150 pl ‘*51-labeled 
6C9.4 MAb’s and 2 ml of 0.05% Rivanol is employed 
to separate bound from free fractions as described under 
Materials and Methods. Total radioactivity added to 
each tube for this particular assay was 47,200 cpm. The 
line labeled NSB indicates no change in nonspecific 
binding whether no protein was present or 1000 ng of 
PB-induced rabbit liver microsomes was present. 
Approximately 80% of all binding occurred 
in the first hour of incubation (Fig. 2), and 
binding was essentially complete by 8 hours. 
The nonspecific binding (NSB), about 12% 
of the total counts, did not increase with 
increased incubation time. This binding was 
not greatly reduced by washing the pellet, or 
by precoating the tubes with either BSA or 
silicon (data not shown). Therefore, this ad- 
ditional wash was not routinely done. 
Table 1 gives an indication of the levels of 
cytochrome P-450b that were found in mi- 
crosomes and mitochondria from both PB- 
induced and noninduced rats. When the 
Rivanol radiometric assay was used, the re- 
sults indicated that, for rat liver, there was 
no detectable P-450b in noninduced micro- 
somes whereas P-450b comprised 11% of all 
microsomal protein in PB-induced animals. 
Similar values were generated in three sepa- 
rate experiments using different rats of the 
same strain. These findings agree with data 
presented by Pickett et al. (11) using another 
immunochemical technique (Table 1). Both 
assay techniques indicated that cytochrome 
P-450b levels were not measurable in non- 
induced rat liver microsomes, whereas P- 
450b was shown to comprise about 10% of 
all microsomal protein in the livers of PB- 
induced rats. One big difference between 
these two different techniques is that the 
rocket immunoelectrophoresis technique as 
performed by Pickett et al. required lOOO- 
fold more microsomes and standard to gen- 
erate linear curves than did the Rivanol 
assay. Total P-450 content of the liver micro- 
somes of both induced and noninduced rats 
as measured by the difference spectrum tech- 
nique of Omura and Sato (12) were similar 
for both studies (Table 1). This method did 
indicate that induction of total P-450 content 
had occurred due to PB treatment, but grossly 
underestimates the extent of induction of the 
P-450b isozyme. 
In an additional experiment, mitochondria 
isolated from the livers of these rats were 
assayed for P-450b content by the Rivanol 
assay and it was shown that 3% of the total 
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FIG. 2. Time-related binding of P-450b and ‘251-labeled 6C9.4 MAb’s when assayed as described under 
Materials and Methods. Each point is the mean of data on duplicate tubes. Nonspecific binding was 
measured in tubes that contained no protein other than that of the MAb solutions. Washing the pellet 
with PBS resulted in very little decrease in background counts. 
mitochondrial protein was P-450b in the PB- be a different isozyme of P-450 sharing similar 
induced rats whereas no P-450b was detected antigenic sites with microsomal P-450b even 
in the mitochondria from noninduced rat though the 6C9 Mabs used in the assay 
liver. It is possible that the P-450b detected showed no cross-reactivity with any P-450 
in the mitochondrial fraction may actually species tested except the rat P-450b. 
TABLE I 
QUANTITATIONOF P-450b IN RATMICROSOMESANDMITOCHONDRIA 






100 PB induced 
50 PB induced 
10 PB induced 
Mitochondria 
1000 noninduced 
1000 PB induced 
8042 + 320 
8600 + 266 0 (ND)b 
1992 + 12 0 0.94 
1852 + 68 0 (1.08)’ 
18,832 + 76 11 (8.9)b 
14,676 + 125 11 2.43 
9701 + 58 10 (2.58)’ 
8546 + 687 0 0.24 
25,230 + 259 3 0.64 
’ P-450 specific contents were measured by the method of Omura and Sato (12) and are expressed as nmol P- 
450/mg protein. All tissue samples were solubilized and assayed as described under Materials and Methods. All 
samples were done in duplicate. 
b These values were generated by the rocket immunoelectrophoresis technique of Pickett et al. (11) using rabbit 
polyclonal antibodies directed against cytochrome P-450b, and liver microsomes from immature Long-Evans rats. 
For noninduced rat liver microsomes the area under the peaks could not be determined (ND). 
’ Values reported by Pickett et al. (1 I) for the same animals mentioned above. 
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DISCUSSION 
An ideal assay for routine use should be 
accurate, sensitive, reproducible, and easy to 
perform. It should also yield results quickly, 
with a minimum of expense, and require 
only materials that are common to a well- 
equipped biological laboratory. The radio- 
metric assay presented here displays all the 
characteristics mentioned above. All deter- 
minations made by this assay were in agree- 
ment with values reported by other labora- 
tories, and were consistent from assay to 
assay. Duplicate samples never varied by 
more than 50 cpm (i.e. ~1% of sample 
counts) for the points of the standard curve, 
even though the sample counts were between 
8000 and 35,000 cpm. Tissue samples showed 
more variation, but standard deviations were 
always less than 8% of the mean for any 
given point. The assay could detect as little 
as 0.2 ng of pure P-450b. For a molecule 
whose molecular weight is in the 100,000 
range, this is a detection limit of 2 X lo-l6 
mol. There have been other recent reports of 
specific radioimmunoassays of cytochrome 
P-450 using iodinated cytochrome P-450 and 
polyclonal antibodies (13,14), but their sen- 
sitivities do not appear to be as great as those 
reported here. Also, these other assays do not 
employ monoclonal antibodies. 
Binding was rapid, reaching 90% of the 
equilibrium value by 4 h. Rivanol is quite 
inexpensive, as are all buffers and reagents 
with the exception of the antigen and the 
labeled MAb. The ?-labeled MAb’s were 
very stable when stored as indicated in 
METHODS. All of the assays represented 
here were performed over a l-month period 
with the same lot of iodinated antibodies, 
with no noticeable loss of binding activity. 
Another advantage of this assay is that the 
addition of large amounts of extraneous pro- 
tein, lipid, etc. does not interfere with binding 
of the antibody to the antigen. 
One disadvantage of this radiometric assay 
is that iodination may destroy the binding 
capacity of an antibody. Several MAb’s di- 
rected against rat liver cytochrome P-450~ 
have been iodinated in this laboratory and 
were found to be inactive with respect to 
binding to the antigen after iodination (data 
not shown). Still, the advantages of sensitivity, 
reproducibility, low cost, ease, and quickness 
that this assay offers should make it advan- 
tageous for quantifying any P-450 isozyme 
for which the iodinated monoclonal antibody 
remains active. 
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